(3S)-4-(8-butyl-2-chloro-7-methylpurin-6-yl)-3-methylmorpholine;1-[4-[8-butyl-7-methyl-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]-3-ethylurea;(3S)-4-(2-chloro-7-methylpurin-6-yl)-3-methylmorpholine
C50H69Cl2N17O4 — CID 159820551
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S)-4-(8-butyl-2-chloro-7-methylpurin-6-yl)-3-methylmorpholine;1-[4-[8-butyl-7-methyl-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]-3-ethylurea;(3S)-4-(2-chloro-7-methylpurin-6-yl)-3-methylmorpholine
(3S)-4-(8-butyl-2-chloro-7-methylpurin-6-yl)-3-methylmorpholine;1-[4-[8-butyl-7-methyl-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]-3-ethylurea;(3S)-4-(2-chloro-7-methylpurin-6-yl)-3-methylmorpholine (PubChem CID 159820551) has the molecular formula C50H69Cl2N17O4 and a molecular weight of 1043.12 g/mol. Its IUPAC name is (3S)-4-(8-butyl-2-chloro-7-methylpurin-6-yl)-3-methylmorpholine;1-[4-[8-butyl-7-methyl-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]-3-ethylurea;(3S)-4-(2-chloro-7-methylpurin-6-yl)-3-methylmorpholine.
Molecular Properties
| Compound Name | (3S)-4-(8-butyl-2-chloro-7-methylpurin-6-yl)-3-methylmorpholine;1-[4-[8-butyl-7-methyl-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]-3-ethylurea;(3S)-4-(2-chloro-7-methylpurin-6-yl)-3-methylmorpholine |
|---|---|
| PubChem CID | 159820551 |
| Molecular Formula | C50H69Cl2N17O4 |
| Molecular Weight | 1043.12 g/mol |
| Exact Mass | 1041.51 |
| IUPAC Name | (3S)-4-(8-butyl-2-chloro-7-methylpurin-6-yl)-3-methylmorpholine;1-[4-[8-butyl-7-methyl-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]-3-ethylurea;(3S)-4-(2-chloro-7-methylpurin-6-yl)-3-methylmorpholine |
| SMILES | CCCCc1nc2nc(-c3ccc(NC(=O)NCC)cc3)nc(N3CCOC[C@@H]3C)c2n1C.CCCCc1nc2nc(Cl)nc(N3CCOC[C@@H]3C)c2n1C.C[C@H]1COCCN1c1nc(Cl)nc2ncn(C)c12 |
| InChI | InChI=1S/C24H33N7O2.C15H22ClN5O.C11H14ClN5O/c1-5-7-8-19-27-22-20(30(19)4)23(31-13-14-33-15-16(31)3)29-21(28-22)17-9-11-18(12-10-17)26-24(32)25-6-2;1-4-5-6-11-17-13-12(20(11)3)14(19-15(16)18-13)21-7-8-22-9-10(21)2;1-7-5-18-4-3-17(7)10-8-9(13-6-16(8)2)14-11(12)15-10/h9-12,16H,5-8,13-15H2,1-4H3,(H2,25,26,32);10H,4-9H2,1-3H3;6-7H,3-5H2,1-2H3/t16-;10-;7-/m000/s1 |
| InChIKey | NMEHOPROCWVBFB-WQUOOGFKSA-N |
| XLogP | 7.57 |
| TPSA | 209.34 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 73 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1043.12 |
| LogP ≤ 5 | 7.57 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 19 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159820551 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.